Showing results (121-130 of 141) with videos related to
Sort By:
Pageof 15
Journal of Crohn'S & Colitis|March 30, 2016
Long-Term Outcome of Patients with Ulcerative Colitis and Primary Non-response to InfliximabKonstantinos Papamichael, Oliviane Rivals-Lerebours, Thomas Billiet, et al.Frontiers in Medicine|January 23, 2023
Pancreatic enzyme supplementation versus placebo for improvement of gastrointestinal symptoms in non-responsive celiac disease: A cross-over randomized controlled trialShakira Yoosuf, Caitlin G Barrett, Konstantinos Papamichael, et al.Journal of Clinical Medicine|October 1, 2020
Vedolizumab Serum Trough Concentrations and Response to Dose Escalation in Inflammatory Bowel DiseaseByron P Vaughn, Andres J Yarur, Elliot Graziano, et al.Journal of Crohn'S & Colitis|October 6, 2017
European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal ['Exit Strategies'] in Inflammatory Bowel DiseaseGlen Doherty, Konstantinos H Katsanos, Johan Burisch, et al.The American Journal of Gastroenterology|May 19, 2023
Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve RemissionAndres J Yarur, Maria T Abreu, Parakkal Deepak, et al.Digestive Diseases and Sciences|February 17, 2021
Lymphoma in Pediatric-Onset Inflammatory Bowel Disease Treated with Infliximab Monotherapy: A Case SeriesAlejandro Llanos-Chea, Jason M Shapiro, Rachel W Winter, et al.The American Journal of Gastroenterology|August 13, 2021
A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel DiseaseAdam S Cheifetz, Maria T Abreu, Waqqas Afif, et al.Digestive Diseases and Sciences|September 22, 2025
Sexual Health and STI Counseling Is Critical but Often Overlooked in IBDAlexander Goldowsky, Andrew Eidelberg, Grace Geeganage, et al.Journal of Crohn'S & Colitis|March 24, 2026
Personalized infliximab rescue therapy to maximize colectomy-free survival in patients with acute severe ulcerative colitisEmmanuel Niyigena, Yannick Hoffert, Waqqas Afif, et al.Open Forum Infectious Diseases|July 14, 2021
Humoral Immune Response to Clostridioides difficile Toxins A and B in Hospitalized Immunocompromised Patients With C difficile InfectionCarolyn D Alonso, Konstantinos Papamichael, Rebecca Sprague, et al.Pageof 15